Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations


Por: Escobar-Chávez J.J., López-Cervantes M., Naïk A., Kalia Y.N., Quintanar-Guerrero D., Ganem-Quintanar A.

Publicada: 1 ene 2006
Resumen:
It is, sometimes, desirable to maintain a constant plasma drug concentration within the therapeutically effective concentration range. The use of high viscosity hydromiscible vehicles such as hydrophilic gels, is one of various approaches for controlled drug delivery, and represents an important area of pharmaceutical research and development. Of these systems, Pluronic F-127 (PF-127) provides the pharmacist with an excellent drug delivery system for a number of routes of administration and is compatible with many different substances. Gels containing penetration enhancers have proven to be especially popular for administering anti-inflammatory medications since they are relatively easy to prepare and very efficacious.

Filiaciones:
Escobar-Chávez J.J.:
 División de Estudios de Posgrado Tecnologia Farmacéutica, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Estado de México 54704, Mexico

López-Cervantes M.:
 División de Estudios de Posgrado Tecnologia Farmacéutica, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Estado de México 54704, Mexico

Naïk A.:
 Centre Interuniversitaire de Recherche et d'Enseignement, Departement de Pharmapeptides, F-74166 Archamps, France

Kalia Y.N.:
 Centre Interuniversitaire de Recherche et d'Enseignement, Departement de Pharmapeptides, F-74166 Archamps, France

Quintanar-Guerrero D.:
 División de Estudios de Posgrado Tecnologia Farmacéutica, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Estado de México 54704, Mexico

Ganem-Quintanar A.:
 División de Estudios de Posgrado Tecnologia Farmacéutica, Facultad de Estudios Superiores Cuautitlán, Universidad Nacional Autónoma de México, Estado de México 54704, Mexico
ISSN: 14821826
Editorial
CANADIAN SOC PHARMACEUTICAL SCIENCES, 3118 DENTISTRY-PHARMACY CENTRE UNIV ALBERTA CAMPUS, EDMONTON, ALBERTA T6G2N8, CANADA, Canada
Tipo de documento: Article
Volumen: 9 Número: 3
Páginas: 339-358
WOS Id: 000245075000007
ID de PubMed: 17207417